- Home
- AEG vs PCVX Comparison
AEG vs PCVX Comparison
Compare AEG & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEG
- PCVX
- Stock Information
- Founded
- AEG 1983
- PCVX 2013
- Country
- AEG Netherlands
- PCVX United States
- Employees
- AEG N/A
- PCVX N/A
- Industry
- AEG Life Insurance
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- AEG Finance
- PCVX Health Care
- Exchange
- AEG Nasdaq
- PCVX Nasdaq
- Market Cap
- AEG 10.5B
- PCVX 9.6B
- IPO Year
- AEG N/A
- PCVX 2020
- Fundamental
- Price
- AEG $6.61
- PCVX $69.46
- Analyst Decision
- AEG Strong Buy
- PCVX Strong Buy
- Analyst Count
- AEG 1
- PCVX 9
- Target Price
- AEG N/A
- PCVX $147.50
- AVG Volume (30 Days)
- AEG 9.3M
- PCVX 1.1M
- Earning Date
- AEG 05-15-2025
- PCVX 05-07-2025
- Dividend Yield
- AEG 3.01%
- PCVX N/A
- EPS Growth
- AEG N/A
- PCVX N/A
- EPS
- AEG 0.39
- PCVX N/A
- Revenue
- AEG $13,292,266,284.00
- PCVX N/A
- Revenue This Year
- AEG N/A
- PCVX N/A
- Revenue Next Year
- AEG $10.18
- PCVX N/A
- P/E Ratio
- AEG $16.62
- PCVX N/A
- Revenue Growth
- AEG N/A
- PCVX N/A
- 52 Week Low
- AEG $5.66
- PCVX $58.10
- 52 Week High
- AEG $6.96
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- AEG 54.42
- PCVX 37.80
- Support Level
- AEG $6.54
- PCVX $68.36
- Resistance Level
- AEG $6.82
- PCVX $76.61
- Average True Range (ATR)
- AEG 0.11
- PCVX 3.10
- MACD
- AEG 0.03
- PCVX 0.01
- Stochastic Oscillator
- AEG 75.00
- PCVX 23.81
About AEG Aegon Ltd. New York Registry Shares
Aegon is a life insurance and long-term savings company listed in the Netherlands. It listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the group that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile-earnings products and recycle funds into capital-light and more predictable strategic businesses.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.